Scientists from Nagoya University in Japan have clarified the relationship between energy levels and fertility in animals and humans. They identified signaling from serotonergic neurons as important for maintaining reproductive ...
May 8, 2024
0
20
Researchers at The Institute of Cancer Research, London, have increased our understanding of how a cancer drug called a PARP inhibitor stops working in women with breast cancer that has spread. This research could ultimately ...
May 8, 2024
0
2
Sodium-glucose cotransporter 2 inhibitors are a class of glucose-lowering drugs known for robust cardiovascular protective properties. However, the side effects induced by sodium-glucose cotransporter 2 inhibition limit application ...
May 8, 2024
0
10
Activated T cells that carry a certain marker protein on their surface are controlled by natural killer (NK) cells, another cell type of the immune system. In this way, the body presumably curbs destructive immune reactions.
May 3, 2024
0
27
For an OB-GYN, one of the worst-case scenarios runs like this: A woman comes in, overjoyed that she is finally pregnant after years of fertility treatments. Then a month later, she finds out she has cancer—news that is ...
May 1, 2024
0
3
A multi-institutional team of investigators has discovered that targeting a specific protein interaction within immunosuppressive breast cancer cells may increase antitumor immune responses in otherwise difficult to treat ...
Apr 30, 2024
0
0
Despite significant progress in treating gastrointestinal (GI) cancers through surgical resection, chemotherapy, radiotherapy, and targeted therapy, the objective response rate (ORR) for immune checkpoint inhibitor (ICI) ...
Apr 30, 2024
0
0
Newly updated guidelines on neuroendocrine tumors developed by an expert at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and collaborators provide clinicians with the latest recommendations ...
Apr 30, 2024
0
0
Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body's own immune system to target tuberculosis, with hopes that they could tackle even the drug-resistant forms of the disease. ...
Apr 26, 2024
0
0
Shutting down a gene called PRMT5 stopped metastatic estrogen receptor-positive (ER+) breast cancer cells from growing after they acquired resistance to a standard therapy known as CDK4/6 inhibitors, UT Southwestern Medical ...
Apr 25, 2024
0
47
